{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:34:10Z","timestamp":1764239650105},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jacl.2010.08.015","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:39:25Z","timestamp":1282451965000},"page":"350-356","source":"Crossref","is-referenced-by-count":24,"title":["Novel therapies and new targets of treatment for familial hypercholesterolemia"],"prefix":"10.1016","volume":"4","author":[{"given":"Anne Carol","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.08.015_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ecl.2008.11.011","article-title":"Other therapies for reducing low-density lipoprotein cholesterol: medications in development","volume":"38","author":"Stein","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacl.2010.08.015_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11883-009-0011-0","article-title":"Novel nonstatin strategies to lower low-density lipoprotein cholesterol","volume":"11","author":"Davidson","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2010.08.015_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MOL.0b013e328248b4ad","article-title":"Antisense apolipoprotein B therapy: where do we stand?","volume":"18","author":"Akdim","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2010.08.015_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/0003088-200948010-00003","article-title":"Lack of pharmacokinetic interaction of mipomersen sodium (ISIS 301012), a 2\u2019-O-methoxyethyl modified antisense oligonucleotide targeting apolipoprotein B-100 messenger RNA, with simvastatin and ezetimibe","volume":"48","author":"Yu","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacl.2010.08.015_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11883-009-0078-7","article-title":"Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia","volume":"12","author":"Thomas","year":"2010","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2010.08.015_bib6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","article-title":"Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B","volume":"114","author":"Kastelein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2010.08.015_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2009.11.069","article-title":"Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy","volume":"55","author":"Akdim","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2010.08.015_bib8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.amjcard.2010.01.003","article-title":"Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia","volume":"105","author":"Akdim","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2010.08.015_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2010.08.015_bib10","unstructured":"ISIS Pharmaceuticals. Press release. Available at: http:\/\/ir.isispharm.com\/phoenix.zhtml?c=222170&p=irol-newsArticle&ID=1385999&highlight. Accessed July 25, 2010."},{"key":"10.1016\/j.jacl.2010.08.015_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1194\/jlr.M002915","article-title":"Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia","volume":"51","author":"Visser","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2010.08.015_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1194\/jlr.E005140","article-title":"Does inhibition of apolipoprotein B synthesis produce foie gras?","volume":"51","author":"Feingold","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2010.08.015_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(10)60364-9","article-title":"Antisense technology to lower LDL cholesterol","volume":"375","author":"Neely","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2010.08.015_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/ncpcardio1251","article-title":"Microsomal triglyceride transfer protein inhibition\u2014friend or foe?","volume":"5","author":"Joy","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacl.2010.08.015_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.08.015_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ncpcardio1250","article-title":"Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia","volume":"5","author":"Samaha","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacl.2010.08.015_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2010.08.015_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd2830","article-title":"Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes","volume":"8","author":"Baxter","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacl.2010.08.015_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410003119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410003119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T11:56:35Z","timestamp":1544270195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287410003119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1933287410003119"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.08.015","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}